These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8488820)

  • 1. Beta 2-microglobulin generation and removal in long slow and short fast hemodialysis.
    Skroeder NR; Jacobson SH; Holmquist B; Kjellstrand P; Kjellstrand CM
    Am J Kidney Dis; 1993 May; 21(5):519-26. PubMed ID: 8488820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On complement net generation in fast hemodialysis: are high blood flow rates bioincompatible?
    Skroeder NR; Kjellstrand P; Holmquist B; Kjellstrand CM; Jacobson SH
    Am J Kidney Dis; 1995 Jun; 25(6):896-903. PubMed ID: 7771486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute symptoms during and between hemodialysis: the relative role of speed, duration, and biocompatibility of dialysis.
    Skroeder NR; Jacobson SH; Lins LE; Kjellstrand CM
    Artif Organs; 1994 Dec; 18(12):880-7. PubMed ID: 7887824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new polyamide membrane (Polyflux 130) in high-flux dialysis.
    Schaefer RM; Gilge U; Goehl H; Heidland A
    Blood Purif; 1990; 8(1):23-31. PubMed ID: 2198889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?
    Haufe CC; Eismann U; Deppisch RM; Stein G
    Kidney Int Suppl; 2001 Feb; 78():S177-81. PubMed ID: 11169006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.
    Lornoy W; Becaus I; Billiouw JM; Sierens L; Van Malderen P; D'Haenens P
    Nephrol Dial Transplant; 2000; 15 Suppl 1():49-54. PubMed ID: 10737167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group.
    Locatelli F; Mastrangelo F; Redaelli B; Ronco C; Marcelli D; La Greca G; Orlandini G
    Kidney Int; 1996 Oct; 50(4):1293-302. PubMed ID: 8887291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting beta 2-microglobulin plasma concentration during hemodialysis.
    Martin-Malo A; Mallol J; Castillo D; Barrio V; Burdiel LG; Perez R; Aljama P
    Int J Artif Organs; 1989 Aug; 12(8):509-14. PubMed ID: 2681000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
    Vanholder RC; Ringoir SM
    Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of a new high-flux cellulose acetate membrane.
    Schaefer RM; Huber L; Gilge U; Bausewein K; Vienken J; Heidland A
    Int J Artif Organs; 1989 Feb; 12(2):85-90. PubMed ID: 2651325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual differences in biocompatibility responses to hemodialysis.
    Skroeder NR; Kjellstrand P; Holmquist B; Kjellstrand CM; Jacobson SH
    Int J Artif Organs; 1994 Oct; 17(10):521-30. PubMed ID: 7896425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dialyzer geometry on granulocyte and complement activation.
    Schaefer RM; Heidland A; Hörl WH
    Am J Nephrol; 1987; 7(2):121-6. PubMed ID: 3496792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies.
    Zingraff J; Beyne P; Ureña P; Uzan M; Nguyen Khoa Man ; Descamps-Latscha B; Drüeke T
    Nephrol Dial Transplant; 1988; 3(3):284-90. PubMed ID: 3140102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of beta 2-microglobulin in patients undergoing blood purification].
    Hou FF
    Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):353-6, 383. PubMed ID: 2269036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hemodialysis membranes on beta 2-microglobulin amyloidosis.
    Jaradat MI; Moe SM
    Semin Dial; 2001; 14(2):107-12. PubMed ID: 11264777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
    Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal.
    Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S
    Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dialyzer reprocessing with Renalin on serum beta-2-microglobulin and complement activation in hemodialysis patients.
    Westhuyzen J; Foreman K; Battistutta D; Saltissi D; Fleming SJ
    Am J Nephrol; 1992; 12(1-2):29-36. PubMed ID: 1415362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.